✦ LIBER ✦

Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesis

✍ Scribed by Daniel R. Budman; Robert Johnson; Barbara Barile; Ronald R. Bowsher; Vincent Vinciguerra; Steven L. Allen; Jonathan Kolitz; Steven C. Ernest; Willi Kreis; Peter Zervos; Jackie Walling

Publisher: Springer
Year: 2001
Tongue: English
Weight: 131 KB
Volume: 47
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800000272

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical and pharmacokinetic stu

Phase I clinical and pharmacokinetic study of LY 195448

✍ James Cassidy; Craig Lewis; Lynn Adams; Albert Setanoians; Martine Bayssas; Geor 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 446 KB

Phase I and pharmacokinetic study of edo

Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3

✍ Yasuhide Yamada; Tomohide Tamura; Noboru Yamamoto; Tatsu Shimoyama; Yutaka Ueda; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 266 KB

Phase I study of methylacetylenic putres

Phase I study of methylacetylenic putrescine, an inhibitor of polyamine biosynthesis

✍ Michael A. Cornbleet; Andrew Kingsnorth; Guy P. Tell; Klaus D. Haegele; Anne-Mar 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 437 KB

In a phase I clinical trial, nine patients with advanced malignancies not amenable to alternative therapy received c~-methyl-~-acetylenic putrescine (MAP), an enzyme-activated, irreversible inhibitor of ornithine decarboxylase (ODC). MAP was given orally in increasing doses to successive groups of t

Phase I and pharmacokinetic study of Tri

Phase I and pharmacokinetic study of Triapine®, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies

✍ Ivana Gojo; Michael L. Tidwell; Jacqueline Greer; Naoko Takebe; Karen Seiter; Ma 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Phase I and pharmacokinetic study of anh

Phase I and pharmacokinetic study of anhydrovinblastine every 3

✍ Nithya Ramnath; Gary N. Schwartz; Patrick Smith; Daniel Bong; Peter Kanter; Joan 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 207 KB

A phase I and pharmacokinetic study of s

A phase I and pharmacokinetic study of sunitinib administered daily for 2

✍ Carolyn D. Britten; Fairooz Kabbinavar; J. Randolph Hecht; Carlo L. Bello; Jim L 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 370 KB